Coya Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Coya Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Coya Therapeutics Inc
Rating: 1.40633325
Author: Trendlyne DVM scores

about

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chroni...

5.06 -0.20 (-3.80%)

34.71% Fall from 52W High

66,494.4

XNAS Volume

XNAS 15 May, 2026 12:03 PM (EDT)

Not Eligible

Expensive Valuation

6.3 / 100

Technically Neutral

49.9 / 100

1Yr Price target upside is 209%

7 analysts

Coya Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Coya Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chroni...

34.71% Fall from 52W High

SWOT Analysis

Coya Therapeutics Inc Live Price Chart